Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 335

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 335
---
,
other than the SEC registration fee, are estimates:

| SEC registration fee         | $ | 23,304 |
| Depositary fees and expenses |   |      * |
| Printing and engraving       |   |      * |
| Accounting services          |   |      * |
| Legal fees and expenses      |   |      * |
| Miscellaneous                |   |      * |
| Total                        | $ |      * |

_______________

*These fees are calculated based on the securities offered and number
of issuances and accordingly cannot be defined at this time.

<div align='center'>LEGAL MATTERS</div>

Certain legal matters in connection
with the validity of the securities offered hereby will passed upon for us by Brown Rudnick LLP, London, United Kingdom. Certain other matters of U.S. federal law will be passed upon for us by Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C., Boston, Massachusetts.

<div align='center'>EXPERTS</div>

The
financial statements of Biodexa Pharmaceuticals PLC as of December 31, 2023, and for the each of the three years in the period then ended,
included in this prospectus and in the registration statement have been so included in reliance on a report of Forvis Mazars LLP (then-named
Mazars LLP), an independent registered public accounting firm, given on authority of said firm as experts in auditing and accounting.
The report on the financial statements for the year ended December 31, 2023, contains an explanatory paragraph in Note 2 regarding our ability to continue as a going concern.

Forvis
Mazars LLP, London, United Kingdom, is a member of the Institute of Chartered Accountants in England and Wales.

<div align='center'>ENFORCEMENT OF CIVIL LIABILITIES</div>

We are incorporated under
the laws of England and Wales. All of our directors and officers of are residents of jurisdictions outside the United States. Our corporate
headquarters is located in the United Kingdom and all or a substantial portion of our assets, and all or a substantial portion of the
assets of our directors and officers, are located outside of the United States. As a result, it may be difficult for you to serve legal
process on us or our directors or have any of them appear in a U.S. court.

We
have appointed Donald J. Puglisi of Puglisi & Associates as our authorized agent upon whom process